AEPCX | CWVIX | AEPCX / CWVIX | |
Total Expense Ratio | 1.59 | 0.89 | 179% |
Annual Report Gross Expense Ratio | 1.59 | 0.95 | 167% |
Fund Existence | 24 years | 26 years | - |
Gain YTD | 9.348 | 12.065 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133B | 898M | 14,811% |
Annual Yield % from dividends | 0.32 | 1.19 | 27% |
Returns for 1 year | 2.57 | 7.59 | 34% |
Returns for 3 years | 23.34 | 38.95 | 60% |
Returns for 5 years | 14.79 | 39.45 | 37% |
Returns for 10 years | 16.82 | 65.02 | 26% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 17.28 | 0.26 | +1.53% |
ProShares UltraShort Nasdaq Biotech | |||
BTAL | 18.83 | 0.25 | +1.35% |
AGF U.S. Market Neutral Anti-Beta | |||
EWZ | 28.14 | -0.01 | -0.04% |
iShares MSCI Brazil ETF | |||
CHY | 10.48 | -0.15 | -1.41% |
Calamos Convertible and High Income Fund | |||
IDGT | 79.70 | -1.48 | -1.83% |
iShares U.S. Digital Infras & RE ETF |